Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Manfredi

Showing results (171-180 of 248) with videos related to

Pageof 25
Sort By:
Clinical Drug Investigation|May 26, 2007
Liposomal Amphotericin B and HIV-Associated Visceral Leishmaniasis : Concerns about Nephrotoxicity and Administration ScheduleSergio Sabbatani, Roberto Manfredi, Ginevra Marinacci, et al.
Acta Dermato-Venereologica|September 30, 2005
Legionnaires' disease associated with macular rash: two casesLeonardo Calza, Elisabetta Briganti, Stefania Casolari, et al.
International Maritime Health|July 7, 2023
Lambliasis-associated Schönlein-Henoch purpura in an Italian traveller: first case report in ItalyAntonio Mastroianni, Sonia Greco, Valeria Vangeli, et al.
Encephalitis (Seoul, Korea)|July 27, 2023
Intrathecal tigecycline is a safe and effective treatment for central nervous system infectionsAntonio Mastroianni, Valeria Vangeli, Maria Vittoria Mauro, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2016
Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patientsLeonardo Calza, Vincenzo Colangeli, Roberto Manfredi, et al.
Recenti Progressi in Medicina|October 30, 2023
Extremely severe thrombocytopenia in both immunocompetent and immunocompromised hosts as a consequence of cytomegalovirus infectionAntonio Mastroianni, Sonia Greco, Valeria Vangeli, et al.
AIDS (London, England)|June 17, 2005
Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot studyLeonardo Calza, Vincenzo Colangeli, Roberto Manfredi, et al.
Scandinavian Journal of Infectious Diseases|April 2, 2011
Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patientsLeonardo Calza, Filippo Trapani, Sara Tedeschi, et al.
HIV Clinical Trials|October 9, 2004
A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infectionRoberto Manfredi, Anna Nanetti, Samanta Morelli, et al.
AIDS (London, England)|June 17, 2005
Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemiaLeonardo Calza, Roberto Manfredi, Vincenzo Colangeli, et al.
Pageof 25

Showing results (171-180 of 248) with videos related to

Sort By:
Pageof 25
Clinical Drug Investigation|May 26, 2007
Liposomal Amphotericin B and HIV-Associated Visceral Leishmaniasis : Concerns about Nephrotoxicity and Administration ScheduleSergio Sabbatani, Roberto Manfredi, Ginevra Marinacci, et al.
Acta Dermato-Venereologica|September 30, 2005
Legionnaires' disease associated with macular rash: two casesLeonardo Calza, Elisabetta Briganti, Stefania Casolari, et al.
International Maritime Health|July 7, 2023
Lambliasis-associated Schönlein-Henoch purpura in an Italian traveller: first case report in ItalyAntonio Mastroianni, Sonia Greco, Valeria Vangeli, et al.
Encephalitis (Seoul, Korea)|July 27, 2023
Intrathecal tigecycline is a safe and effective treatment for central nervous system infectionsAntonio Mastroianni, Valeria Vangeli, Maria Vittoria Mauro, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2016
Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patientsLeonardo Calza, Vincenzo Colangeli, Roberto Manfredi, et al.
Recenti Progressi in Medicina|October 30, 2023
Extremely severe thrombocytopenia in both immunocompetent and immunocompromised hosts as a consequence of cytomegalovirus infectionAntonio Mastroianni, Sonia Greco, Valeria Vangeli, et al.
AIDS (London, England)|June 17, 2005
Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot studyLeonardo Calza, Vincenzo Colangeli, Roberto Manfredi, et al.
Scandinavian Journal of Infectious Diseases|April 2, 2011
Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patientsLeonardo Calza, Filippo Trapani, Sara Tedeschi, et al.
HIV Clinical Trials|October 9, 2004
A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infectionRoberto Manfredi, Anna Nanetti, Samanta Morelli, et al.
AIDS (London, England)|June 17, 2005
Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemiaLeonardo Calza, Roberto Manfredi, Vincenzo Colangeli, et al.
Pageof 25